BioNTech and Bristol Myers Squibb Unveil Promising Phase 2 Data for Pumitamig in Lung Cancer

thestockmarketwatch.com · 2026-10-25

BioNTech SE (BNTX) and Bristol Myers Squibb Company (BMY) announced encouraging results from their Phase 2 ROSETTA Lung-107 clinical trial. The study